Ultrathin-strut biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in acute myocardial infarction: a randomized controlled trial

2 September 2019 (09:06 - 09:24)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Doctor Juan F Iglesias

University hospitals of Geneva, Geneva (Switzerland)

4 More presentations in this session

Presentation thumbnail

Immediate versus Delayed Stenting After Primary Percutaneous Reperfusion in ST-Elevation Myocardial Infarction: The PRIMACY Bayesian Randomized Controlled Trial

Doctor M. Jolicoeur (Montreal, CA)

Presentation thumbnail

Percutaneous left atrial appendage closure versus novel anticoagulation agents in high-risk atrial fibrillation patients (PRAGUE-17 study)

Doctor P. Osmancik (Prague, CZ)

Presentation thumbnail

Low-dose rivaroxaban after left atrial appendage closure: The randomized ADRIFT study

Professor G. Montalescot (Paris, FR)

Presentation thumbnail

Randomized, Multicenter Comparison of Intensified versus Standard Loading Strategies with P2Y12-Receptor-Inhibitors in Patients Undergoing Elective PCI

Professor J. Mehilli (Landshut, DE)

Access the full session

Session thumbnail

Late Breaking Science in Intervention

The Event

ESC Congress 2019

2 September 2019 09:06 CET

You may be interested in

Congress Session

Complex PCI in practice: tips and tricks to take home

Congress Presentation

Outcomes following percutaneous coronary intervention in a tertiary cardiac centre in the UK

Congress Presentation

Clinical outcomes of patients undergoing percutaneous coronary intervention and transcatheter aortic valve implantation versus coronary artery bypass grafting and surgical aortic valve replacement

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources